श्री सिद्धार्थ श्रीनिवासन, सीईओ, लुपिन डिजिटल हेल्थ (LDH), तकनीक के माध्यम से रोगियों के बेहतर परिणाम सुनिश्चित करने पर केंद्रित डिजिटल थेरेप्यूटिक्स पहलों का नेतृत्व कर रहे हैं। टेक-ड्रिवन व्यवसायों को बड़े पैमाने पर आगे बढ़ाने का अनुभव रखने वाले वे इससे पहले एक दशक तक टाटा समूह से जुड़े रहे। उन्होंने एस.पी. जैन से पीजीडीएम और वीएनआईटी से बी.टेक की डिग्री प्राप्त की है। डॉ. सौम्या सिंह, क्रिएटिव एडिटर, उनसे स्वास्थ्य सेवा में डिजिटल थेरेप्यूटिक्स की भूमिका पर बातचीत कर रही हैं।

भारत में शहरी और ग्रामीण क्षेत्रों में डिजिटल थेरेप्यूटिक्स किस प्रकार स्वास्थ्य सेवाओं को बदल रहे हैं?

डिजिटल थेरेप्यूटिक्स भारत में स्वास्थ्य सेवाओं के परिदृश्य को तेजी से बदल रहे हैं।

• शहरी क्षेत्रों में टेलीहेल्थ और मोबाइल हेल्थ सॉल्यूशन्स का व्यापक रूप से उपयोग हो रहा है।
• ग्रामीण क्षेत्रों में भी धीरे-धीरे टेलीहेल्थ और डिजिटल थेरेप्यूटिक्स का अपनापन बढ़ रहा है, क्योंकि लोग विशेषज्ञ डॉक्टरों की सेवाओं तक पहुँच बनाना चाहते हैं।

अब ध्यान संक्रामक रोगों से हटकर गैर-संक्रामक रोगों (NCDs) पर केंद्रित हो गया है, जिनमें कार्डियोमेटाबोलिक बीमारियाँ (जैसे उच्च रक्तचाप और मधुमेह) शामिल हैं। इन स्थितियों से भारत की बड़ी आबादी प्रभावित है, और डिजिटल थेरेप्यूटिक्स इन्हें नियंत्रित करने में महत्वपूर्ण भूमिका निभा सकते हैं।

इसके अलावा, श्वसन रोग, महिला स्वास्थ्य, कैंसर, नवजात शिशु देखभाल और मानसिक स्वास्थ्य जैसे क्षेत्रों में भी उल्लेखनीय प्रगति हो रही है।

कार्डियोलॉजी (हृदय रोग विज्ञान) में डिजिटल थेरेप्यूटिक्स की क्या भूमिका है?

हृदय रोगों में डिजिटल थेरेप्यूटिक्स तीन प्रमुख पहलुओं में मददगार हैं:

• सक्रिय निगरानी (Active Monitoring): मरीज अपने लक्षण और महत्वपूर्ण संकेत (Vitals) वास्तविक समय में साझा कर सकते हैं, जिससे सही समय पर हस्तक्षेप संभव होता है।
• अनुपालन (Adherence): यह सुनिश्चित करता है कि मरीज नियमित रूप से दवा लें और समय-समय पर चेकअप करवाएँ।
• जागरूकता और पुनर्वास (Awareness & Rehabilitation): मरीजों को जीवनशैली सुधारने और रिकवरी में व्यापक सहायता प्रदान की जाती है।

डिजिटल थेरेप्यूटिक्स प्लेटफ़ॉर्म में डेटा गोपनीयता और सुरक्षा कैसे सुनिश्चित की जाती है?

• कानूनों का पालन: भारत में डिजिटल पर्सनल डेटा प्रोटेक्शन बिल और अमेरिका में HIPAA जैसे नियम।
• सूचना सुरक्षा प्रणाली: ISO 27001 जैसे मानकों के अनुसार।
• नियमित ऑडिट और जाँच।
• डेटा एन्क्रिप्शन और सीमित एक्सेस।
• सुरक्षित क्लाउड सेवा प्रदाताओं के साथ साझेदारी।
• मरीजों को अपने डेटा पर नियंत्रण: वे चाहें तो जानकारी एक्सेस या डिलीट कर सकते हैं।

AI एकीकरण डिजिटल थेरेप्यूटिक्स की प्रभावशीलता कैसे बढ़ा रहा है?

• प्रीडिक्टिव मॉडल्स: संभावित स्वास्थ्य समस्याओं का पहले से अनुमान।
• नेचुरल लैंग्वेज प्रोसेसिंग: चैटबॉट्स और वर्चुअल असिस्टेंट्स मरीजों के सवालों का जवाब देते हैं।
• क्लिनिकल डिसीजन सपोर्ट: डॉक्टरों को मरीज की जानकारी का सारांश और व्यक्तिगत इलाज योजनाएँ सुझाना।
• जोखिम मूल्यांकन (Risk Assessment): री-अडमिशन या जटिलताओं की संभावना का अनुमान।
• कंप्यूटर विज़न: स्मार्टफोन इमेज से बीमारियों का आकलन।

आने वाले 5–10 वर्षों में कौन-सी नई तकनीकें डिजिटल थेरेप्यूटिक्स पर सबसे बड़ा प्रभाव डालेंगी?

• वेयरेबल्स (Wearables): स्मार्टवॉच और अन्य उपकरणों का व्यापक उपयोग।
• गैर-आक्रामक मॉनिटरिंग: बिना सुई या कफ के ब्लड प्रेशर और ग्लूकोज की निगरानी।
• AI-आधारित बिहेवियरल मॉडल्स: बेहतर अनुपालन सुनिश्चित करने हेतु।
• कंप्यूटर विज़न: व्यायाम की सही तकनीक पर वास्तविक समय फीडबैक।
• ऑगमेंटेड रियलिटी (AR): मरीज शिक्षा और सर्जिकल प्लानिंग में उपयोग।

भारत और वैश्विक स्तर पर डिजिटल थेरेप्यूटिक्स बाजार का भविष्य कैसा है?

• भारत में: AI-आधारित हेल्थकेयर बाजार तेजी से विस्तार कर रहा है।
• वैश्विक स्तर पर: वेयरेबल्स का बाजार उल्लेखनीय रूप से बढ़ने की संभावना है।
• वर्तमान में स्वास्थ्य सुविधाओं में डिजिटल थेरेप्यूटिक्स का उपयोग अभी भी कम है, जिससे वृद्धि की अपार संभावना है।

हृदय रोगों की देखभाल में डिजिटल थेरेप्यूटिक्स का दृष्टिकोण क्या है?

विशेषज्ञ टीम (केयर मैनेजर, न्यूट्रिशनिस्ट, व्यायाम विशेषज्ञ)।

• मरीज, डॉक्टर और देखभालकर्ताओं के लिए ऐप इकोसिस्टम।
• मान्यता प्राप्त चिकित्सा उपकरणों का एकीकरण।
• पोस्ट-प्रोसीजर से लेकर क्रॉनिक कार्डियक कंडीशन्स तक की देखभाल।
• एविडेंस-बेस्ड केयर: नवीनतम क्लिनिकल गाइडलाइन्स पर आधारित।

डिजिटल थेरेप्यूटिक्स स्वास्थ्य सेवाओं को अधिक सुलभ और किफायती कैसे बनाते हैं?

• दूरस्थ परामर्श और मॉनिटरिंग, अस्पताल जाने की आवश्यकता कम।
• विशेषज्ञों तक पहुँच, खासकर डॉक्टरों की कमी वाले क्षेत्रों में।
• यात्रा और आवास जैसे छिपे हुए खर्चों में कमी।
• नियमित देखभाल के बीच निरंतर समर्थन, जिससे जटिलताओं से बचाव।
• AI और तकनीक के ज़रिए बड़े पैमाने पर व्यक्तिगत देखभाल।
• मरीजों को आत्म-प्रबंधन के लिए ज्ञान और उपकरण उपलब्ध।

The post स्वास्थ्य सेवा में बदलाव: भारत और वैश्विक स्तर पर डिजिटल थेरेप्यूटिक्स की भूमिका appeared first on InnoHEALTH magazine.

Developing Countries:

In developing countries, ChatGPT can help improve access to healthcare by providing remote consultations and diagnostics. For example, patients in rural areas may not have access to specialized doctors or medical facilities. ChatGPT can be used to provide remote consultations and connect patients with the appropriate medical professionals.

In addition, ChatGPT can be used to develop predictive models to identify outbreaks of diseases and track the spread of infectious diseases in real-time. This can help public health officials and medical professionals to respond quickly and effectively to prevent the spread of diseases.

One example of this is the use of ChatGPT to diagnose COVID-19. In collaboration with publicly and privately funded hospitals in such countries, chatbots have been developed that could assess a person’s risk of COVID-19 based on their symptoms and travel history. This helped to ease the burden on healthcare workers and enabled more people to access testing and care.

Third World Countries:

In third world countries, ChatGPT can help address the shortage of medical professionals and lack of access to healthcare. ChatGPT can be used to provide basic health information, such as how to prevent diseases, manage chronic conditions, and address common health concerns. Additionally, ChatGPT can be used to develop predictive models to identify outbreaks of diseases and track the spread of infectious diseases in real-time.

One example of this is the use of ChatGPT in African countries to provide health information to people living in remote areas. In collaboration with the World Health Organization (WHO), a chatbot was developed that could provide information on a range of health topics, including HIV/AIDS, malaria, and maternal health. This helped to improve access to healthcare in areas where medical professionals are scarce.

Overall, ChatGPT and other language models have the potential to transform healthcare systems around the world by improving access to healthcare, enhancing the quality of care, and advancing medical research. However, it is important to consider the ethical and privacy implications of using AI in healthcare and ensure that these technologies are developed and deployed in a responsible manner.

“Composed by: Ela Vashishtha, a healthcare analytics and planning leader at Texas Health Resources, USA, is driving data analytics and process improvement initiatives to address complex business challenges in healthcare. With a strong track record, she has successfully streamlined operations and improved healthcare efficiencies. Managing operational excellence for over 27 hospitals, she has spearheaded the implementation of real-time data monitoring and digital products, such as telehealth and remote patient monitoring. Ela’s expertise also includes the use of predictive tools for COVID and flu, as well as enhancing hospital quality indicators.”

The post Effect of Language Models on Global Healthcare appeared first on InnoHEALTH magazine.

The Genome: The Blueprint of Life

The genome can be thought of as the blueprint of life. It encompasses all the genetic material present in an organism, including the DNA sequences that make up genes. Genes are responsible for encoding proteins, the building blocks of life, which carry out essential functions in our bodies. The genome also includes non-coding DNA regions that regulate gene expression and contribute to various aspects of our biology.

The human genome consists of approximately 3 billion base pairs, which are arranged in a unique sequence. This sequence determines the genetic code that provides instructions for the formation and functioning of every cell in our bodies. The genome is organised into chromosomes, with each cell typically containing 23 pairs of chromosomes, including the sex chromosomes.

Advancements in genomics technologies, such as DNA sequencing, have revolutionised our ability to decipher and analyse the genome. This has led to groundbreaking discoveries about the genetic basis of diseases, the identification of genetic variations associated with traits and conditions, and the development of personalised medicine approaches.

The Phenome: An Expression of Our Genes

The phenome encompasses all the observable traits, characteristics, and behaviors of an organism. It is the result of the complex interplay between genetic factors and environmental influences. Phenotypes can vary widely among individuals, even if they share similar genetic backgrounds, due to the influence of external factors such as lifestyle, diet, and exposure to environmental factors.

Phenotypes can include physical attributes (e.g., height, eye colour), physiological traits (e.g., blood pressure, cholesterol levels), and disease susceptibility or resistance. They can also encompass behavioural traits, cognitive abilities, and responses to medications. By studying phenotypes, researchers gain valuable insights into the interplay between genes and the environment and how they contribute to variations in health outcomes and disease risk.

The Genome-Phenome Interaction: A Complex Interplay

The relationship between the genome and the phenome is a complex interplay influenced by multiple factors. While our genes provide the foundation for our biological makeup, they do not act alone in determining our phenotypic traits. Environmental factors, such as diet, lifestyle, exposure to toxins, and social determinants of health, also play significant roles in shaping our phenotypes.

The genome-phenome interaction involves a dynamic process influenced by gene expression, epigenetics (the study of heritable changes in gene activity without changes to the underlying DNA sequence), and gene-environment interactions. Gene expression refers to the activation or deactivation of specific genes in response to various internal and external stimuli.

Understanding the genome-phenome interaction is essential for unravelling the complexities of human health and disease. It enables researchers to identify genetic variations associated with specific phenotypes, discover underlying molecular mechanisms, develop targeted therapies, and improve disease prevention and management strategies. Additionally, it provides insights into how environmental factors can modify gene expression and impact health outcomes.

In summary, genomics and phenomics provide a comprehensive understanding of the complex interplay between our genes and the observable traits and characteristics they influence. By studying the genome-phenome interaction, researchers are uncovering valuable insights that have far-reaching implications for personalised medicine, disease prevention, and improving overall health outcomes.

From Genes to Disease: Understanding the Connection

Understanding the connection between genes and disease is a crucial area of research that has the potential to revolutionise our approach to healthcare. Genes play a significant role in determining our susceptibility to various diseases, and unravelling this connection can provide valuable insights into disease prevention, early diagnosis, and targeted treatments.

Genes are segments of DNA that contain the instructions for building and maintaining our bodies. They carry the genetic information that is passed down from our parents and are responsible for the traits and characteristics we inherit. However, genes can also harbour mutations or variations that can impact our health.

Genetic research has identified specific genes and genetic variants that are associated with various diseases. Some diseases, known as monogenic disorders, are caused by mutations in a single gene. Examples include cystic fibrosis, sickle cell anaemia, and Huntington’s disease. Understanding the specific gene mutations that underlie these disorders is crucial for diagnosis and targeted interventions.

In addition to monogenic disorders, genes also play a role in complex diseases such as diabetes, cardiovascular disease, cancer, and neurodegenerative disorders. These diseases result from a combination of genetic variations, environmental factors, and lifestyle choices. Identifying the genetic risk factors associated with complex diseases can help in assessing an individual’s susceptibility and implementing preventive strategies.

The Impact of Genomic Information on Health Outcomes

The availability of genomic information has profound implications for health outcomes. It enables healthcare providers to identify individuals who are at higher risk for developing certain diseases, allowing for targeted screening and early intervention. For example, individuals with a high genetic risk for breast cancer may undergo more frequent screenings or consider risk-reducing strategies such as preventive surgeries or targeted therapies.

Genomic information also plays a crucial role in precision medicine, where treatments are tailored to an individual’s genetic profile. Pharmacogenomics, a branch of precision medicine, examines how genetic variations influence an individual’s response to medications. This information helps guide medication selection and dosing, improving treatment efficacy and reducing adverse drug reactions.

Furthermore, genomic information contributes to our understanding of disease biology and the development of novel therapies. By identifying specific genes or molecular pathways involved in disease progression, researchers can develop targeted drugs or gene therapies that address the underlying causes of the disease, potentially leading to more effective treatments.

The Phenotypic Impact: How Genes Shape Health

Phenotype refers to the observable characteristics of an individual, such as physical traits, behaviors, and disease manifestations. Genes play a fundamental role in shaping our phenotype. However, it is important to note that while genes provide the blueprint, other factors such as environmental influences and lifestyle choices can modify or interact with genetic predispositions.

Understanding the phenotypic impact of genes is a complex task. Genetic variations can have varying degrees of influence on an individual’s health outcomes. Some variations may have a strong causal relationship with a disease, while others may increase susceptibility or modify the disease course.

Additionally, gene-gene interactions and gene-environment interactions contribute to the phenotypic complexity. Two individuals with the same genetic variant may have different disease outcomes depending on their environmental exposures or other genetic factors.

Advances in technologies like high-throughput sequencing and bioinformatics are enhancing our ability to uncover these complex gene-environment interactions and decipher the phenotypic impact of genetic variations. This knowledge is crucial for understanding disease mechanisms, predicting disease risk, and developing personalised interventions that target the specific genetic and environmental factors involved.

Genome to Phenome: The Journey of Precision Medicine

Precision medicine has revolutionised the healthcare landscape by recognizing the unique genetic makeup of individuals and tailoring treatments accordingly. At the core of precision medicine is the concept of transitioning from the genome, which represents an individual’s complete set of genetic information, to the phenome, which encompasses the observable traits and characteristics influenced by those genes. This journey from the genome to the phenome has the potential to unlock valuable insights and improve health outcomes in remarkable ways.

Genetic Testing and Its Role in Improving Health Outcomes

Genetic testing plays a crucial role in the journey from the genome to the phenome. It involves the analysis of an individual’s genetic material to identify variations or mutations that may be associated with specific diseases or conditions. By undergoing genetic testing, individuals gain insight into their genetic predispositions, allowing for early detection, prevention, and personalised treatment strategies. Genetic testing helps healthcare providers make informed decisions, prescribe appropriate medications, and monitor potential risks, resulting in improved health outcomes.

Genetic testing encompasses various techniques, including whole genome sequencing, targeted gene panel testing, and specific gene variant analysis. The choice of genetic testing method depends on the clinical context and the specific questions being addressed. As technology advances, genetic testing is becoming more accessible, cost-effective, and informative, empowering individuals to take an active role in managing their health.

The Use of Genomic Information in Clinical Practice

Integrating genomic information into clinical practice is a critical step in the journey from the genome to the phenome. By considering an individual’s genomic profile alongside their medical history, lifestyle factors, and environmental influences, healthcare providers can develop tailored treatment plans. Genomic information provides valuable insights into disease risk, drug response, and prognosis, enabling personalised and targeted interventions.

In oncology, for example, genomic profiling of tumours helps identify specific genetic alterations driving the disease. This information guides treatment decisions, such as the selection of targeted therapies or immunotherapies. In other medical specialties, genomic information assists in diagnosing rare genetic disorders, determining optimal drug dosages based on individual metabolism, and identifying potential adverse drug reactions.

Challenges in Translating Genetic Insights into Health Improvements

While the journey from the genome to the phenome holds immense promise, it also presents challenges that need to be addressed. One significant challenge is the interpretation of genetic data. Analysing and understanding the vast amount of genetic information requires sophisticated bioinformatics tools and expertise. Ensuring the accuracy, reliability, and clinical relevance of genetic testing results is crucial for effective translation into clinical practice.

Another challenge lies in the ethical and privacy considerations associated with genetic testing. The potential for discrimination based on genetic information, the impact on insurance coverage, and the proper handling of sensitive data require careful attention and robust legal and ethical frameworks.

Furthermore, there is a need for improved education and awareness among healthcare providers and the general public. Healthcare professionals must be equipped with the knowledge and skills to interpret genetic information and effectively communicate with patients about the implications and limitations of genetic testing.

To overcome these challenges, collaboration between researchers, clinicians, genetic counsellors, policymakers, and patients is vital. Ongoing research, technological advancements, and the establishment of guidelines and standards can help ensure the responsible and effective translation of genetic insights into improved health outcomes.

The journey from the genome to the phenome represents the future of precision medicine. Genetic testing and the use of genomic information in clinical practice empower healthcare providers to deliver personalised and targeted treatments, resulting in improved health outcomes. However, addressing challenges related to interpretation, ethics, privacy, and education is crucial for realising the full potential of genetic insights in improving healthcare for individuals and populations.

Future Directions: Genomics, Phenomics, and Personalized Healthcare

The field of genomics has made remarkable strides in recent years, offering a deeper understanding of our genetic makeup and its impact on health and disease. The integration of genomics with phenomics—the study of how genes interact with the environment and influence observable traits—holds immense potential for personalised healthcare. As we look towards the future, several key directions are emerging, shaping the landscape of genomics, phenomics, and personalised healthcare.

1. Advancements in Genomic Technologies

Continued advancements in genomic technologies are expected to enhance our ability to analyse and interpret genetic data. Next-generation sequencing techniques, such as whole genome sequencing and whole exome sequencing, are becoming more affordable and accessible, enabling a more comprehensive assessment of an individual’s genetic profile. Additionally, advancements in high-throughput techniques and bioinformatics tools are facilitating large-scale analysis of genomic data, contributing to a deeper understanding of the complex interplay between genes and health outcomes.

2. Integration of Multi-Omics Data

The integration of genomics with other omics disciplines, such as transcriptomics, proteomics, metabolomics, and epigenomics, is anticipated to provide a more holistic view of human biology and disease. This multi-omics approach will enable researchers to uncover intricate molecular mechanisms underlying health and disease, offering novel insights into disease etiology, identification of biomarkers, and development of targeted therapies.

3. Population Genomics and Precision Public Health

Population genomics aims to characterise genetic variation and its distribution within populations. Large-scale genomic studies, such as genome-wide association studies (GWAS) and population-based sequencing initiatives, are generating extensive genomic data across diverse populations. By integrating population genomics with phenotypic and environmental data, precision public health strategies can be developed to identify population-specific health risks, tailor preventive measures, and improve public health interventions.

4. Artificial Intelligence and Machine Learning

Artificial intelligence (AI) and machine learning (ML) techniques are revolutionising the analysis and interpretation of genomic and phenomic data. These technologies can process vast amounts of data, identify patterns, and make predictions, facilitating the discovery of novel genetic associations, development of predictive models, and personalised treatment recommendations. AI and ML also hold promise in uncovering previously unrecognised genetic relationships and elucidating complex gene-environment interactions.

5. Ethical, Legal, and Social Implications (ELSI)

As genomics and personalised healthcare progress, it is essential to address the ethical, legal, and social implications that arise. Ensuring privacy and confidentiality of genomic data, promoting equity in access to genetic testing and personalised treatments, and addressing potential biases and discrimination are critical considerations. Collaborative efforts between researchers, policymakers, and ethicists are necessary to develop guidelines and frameworks that safeguard patient rights and promote responsible use of genomic information.

Conclusion: The Promising Intersection of Genomics and Phenomics

The convergence of genomics and phenomics holds tremendous promise for personalised healthcare. By understanding the complex interplay between genes, environment, and observable traits, healthcare can become more targeted, preventive, and effective. Genomic insights can aid in early disease detection, identification of individuals at higher risk, and tailoring treatment plans based on an individual’s genetic profile. Additionally, the integration of phenomics data allows for a more comprehensive understanding of an individual’s health, considering lifestyle, environmental factors, and social determinants.

However, realising the full potential of genomics and phenomics in personalised healthcare requires interdisciplinary collaborations, investment in research and infrastructure, and the development of robust data sharing platforms. By embracing these challenges and ethical considerations, we can leverage genomics and phenomics to usher in a new era of healthcare that is truly patient-centred, precise, and capable of improving health outcomes for individuals and populations alike.

Composed by: “Varsha, proficient as a Business Analyst, has an educational foundation in healthcare IT, acquired through a PGDHM from IIHMR Delhi. Her primary interest rests at the intersection of healthcare and technology, with a specific focus on harnessing cutting-edge tech solutions to revolutionize patient care and enhance healthcare systems. Her work areas comprise optimizing healthcare data flow and improving operational efficiency, driving enhanced patient care and system robustness.”

The post From genome to phenome: The impact of genetic insights on health outcomes appeared first on InnoHEALTH magazine.

Positive of Its adoption

1. Unparalleled Responsiveness: ChatGPT can conduct numerous interactions concurrently, a feat unattainable by human counterparts. This efficiency lends itself particularly well to customer support roles, enhancing response rates and user satisfaction.

2. Round-the-Clock Operation: Free of human constraints such as fatigue or the need for sleep, ChatGPT provides a continuous service, essential for roles necessitating 24/7 availability. In an era of instant gratification, this perpetual operation elevates user experience significantly.

3. Extensive Knowledge Base: Leveraging vast datasets and machine learning, ChatGPT offers an encyclopedic range of topic comprehension. This feature permits it to create contextually relevant, human-like responses to a diverse array of prompts.

4. Scalable Solution: ChatGPT can be effectively and economically scaled to serve an extensive user base, since its ability to understand natural language and create meaningful context out of textual conversation makes it easier for a non technical person to adopt and use at ease making it a cost-effective solution for large organizations.

5. Multilingual Proficiency: Its advanced linguistic capabilities, extending across numerous languages, render it an invaluable tool in our globally connected world.

Negatives of its Adoption

1. Contextual Misunderstanding: Despite its proficiency, ChatGPT lacks a genuine understanding of the subtleties and nuances of human language, emotion, and cultural context. This lack can lead to inaccurate interpretations and inappropriate responses.

2. Potential for Ethical Misuse: The model’s capacity to generate convincing content raises concerns about misuse, including the fabrication of misleading information, spam generation, or more insidious forms of deception.

3. Bias Propagation: ChatGPT’s responses hinge on its training data. If this data is skewed or biased, it could inadvertently perpetuate harmful stereotypes or unfair depictions.

4. Accountability Concerns: With potential harms from AI content, delineating responsibility is complex. The matter of whether accountability lies with the AI developers, its users, or the AI itself remains contentious.

5.Employment Implications: As AI technologies increasingly automate tasks, concerns about employment displacement intensify. The prospect of AI rendering certain jobs obsolete raises serious societal and economic questions.

6. Graph data limitations: Inability to process visual data such as graph.

In conclusion, ChatGPT is a powerful, transformative technology with immense benefits including efficiency, continuous operation, broad-based knowledge, scalability, and linguistic versatility. However, its limitations underscore essential considerations, encompassing context comprehension, ethical misuse, propagation of biases, accountability, and the societal impact on jobs. As the AI landscape evolves, these aspects warrant careful consideration to ensure responsible and equitable application of such technology, before humans are replaced by computers as is reflective in image below.

The post ChatGPT new buzzword of AI: Pros and Con of its adoption appeared first on InnoHEALTH magazine.

The post The Vulnerability of Medical Institutions to Cyber Attacks appeared first on InnoHEALTH magazine.

Likewise, the global trends, the growth of the Internet in India is incredibly fast-paced, with an estimated addition of 10 million active users each month. Along with the increase in the number of users, the adoption rate of going digital by various stakeholders in our society is also growing exponentially. Unfortunately, this also increases our vulnerability to potential hacks or security breaches that come from individual hackers to organized groups to even attacks from nation states. Cybersecurity, thus, entails protection of our cyberspace, and all the critical infrastructures like banking and finance, defense, healthcare, manufacturing, nuclear reactors, and commercial facilities from being the target to any sort of attack, damage, misuse or act of espionage.

The healthcare industry is particularly vulnerable to cyber threats not least because of the minimal amount of investment they put in cybersecurity measures. Hospitals, insurance companies, pharmacies, developers/ owners of healthcare websites, manufacturers of medical devices, or handsets, or third-party vendors to which sensitive patient data gets shared; all represent a leaky pipeline through which hackers can enter a system and cause extensive damage. The types of attacks can include access to patient’s medical history, prescriptions, financial and personal details or using the Internet of Medical Things to disrupt implanted medical devices or devices like drug infusion pumps. Healthy cybersecurity practices have, therefore, never been more important than today when a ransomware attack like WannaCry has the potential to literally shut down a country’s (UK) National Health Service.

Healthcare specific provisions

While the above-mentioned regulations provide a general legal cybersecurity framework for all the organizations, no separate provisions are in place viz a viz the healthcare sector. India decided to fill in this gap last year when the Ministry of Health and Family Affair, the Government of India proposed the Digital Information Security in Healthcare Act (DISHA) and placed it in public domain on 21 March 2018 for comments by various stakeholders. DISHA aims to ensure reliability, data privacy, confidentiality, and security of digital health data. The act, applicable to entire India except for Jammu and Kashmir, establishes eHealth Authorities and Health Information Exchanges at the state and national levels while also outlining the guidelines on standardizing/ regulating the processes related to the collection, storing, transmission and use of digital health data (DHD) in India.

Accordingly, DHD means any electronic record of health-related information

• concerning the physical or mental health of a person
• on any health service provided to an individual
• on a donation of any body part of any bodily substance
• derived from testing or examination of a body part or bodily substance
• collected during providing health services
• relating to details of the clinical establishment accessed by a person

DISHA also specifies the rights of the owner of digital health data, outlines the purposes for which DHD can be collected and explicitly mentions all clinical establishments holding DHD to be duty-bound in maintaining privacy and confidentiality of the patient’s data. Importantly, DISHA touches upon what constitutes a breach of digital health data, compensation in the event of one happening and what punishments an individual or a company might face if convicted of a cybercrime.

The post Cybersecurity Trends, Challenges, and Threats in Healthcare appeared first on InnoHEALTH magazine.

In a recent healthcare conference, the people were unaware when I spoke about how on October 21, 2013, the former US Vice President Dick Cheney’s doctors disabled his pacemaker’s wireless capabilities to thwart possible assassination attempts. To this, everyone had an issue on accountability. It remains unanswered that who would be liable, the doctor, hospital, company which provided pacemaker or the insurance company. Amidst all this, nobody was concerned about the patient as none present there questioned it. Maybe we are awaiting a major catastrophe to happen to put our minds to work. It is our endeavor to equip the healthcare community to this aspect of digital health.

The post Cyber4Healthcare: An Issue of Today & Tomorrow appeared first on InnoHEALTH magazine.

“A journey of a thousand miles begins with a single step.” The Digital Information Security in Healthcare Act (‘DISHA’) is that firm first step taken by the Indian Government in the long journey to secure the healthcare data of patients in India. The question we need to ask ourselves is that Why DISHA is the need of the hour? Why do we need to safeguard the electronic health record in hospitals?

The draft of the act was made public in November 2017 by Ministry of Health and Family Welfare. The word ‘Disha’ means direction, the GoI has taken the first step in the direction of safeguarding the digital health record. For this InnovatioCuris has also taken the first step towards having a concrete discussion about ‘Challenges in the implementation and opportunities for making health sector DISHA and data protection ready’. There were panelists from various renowned government, private hospitals, and healthcare IT firms.

The post How Crucial is DISHA Act for Healthcare Industry? appeared first on InnoHEALTH magazine.

The post Innovation Pitches from Global & Indian Companies appeared first on InnoHEALTH magazine.